Search

Molnupiravir – the first antiviral pill for early COVID-19

Molnupiravir as post-exposure prophylaxis against COVID-19

Fluvoxamine – background and a preliminary study

Fluvoxamine – generic antidepressant looks very promising in treating early COVID

Why many drugs fail their development pathway

Other oral antivirals under development for COVID-19

• A U.S. study has found that certain health conditions appear to increase the risk for frailty
• These conditions were stroke, diabetes, lung and liver disease
• Screening, preventing…

The Anonymous HIV Testing Program in London, Ontario, provides HIV prevention, testing and counselling services to at-risk populations on an outreach basis in and around the city.

This article summarizes several trends and factors that may have influenced the rising hepatitis C rates between 2014 and 2018.

A virtual repository of pre-parenting information for people living with HIV and care providers.